Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linzee Mabrey

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Innate Immunity|November 22, 2021
TLRs in COVID-19: How they drive immunopathology and the rationale for modulationF Linzee Mabrey, Eric D Morrell, Mark M Wurfel
AMIA ... Annual Symposium Proceedings. AMIA Symposium|March 21, 2022
Identifying ARDS using the Hierarchical Attention Network with Sentence Objectives FrameworkKevin Lybarger, Linzee Mabrey, Matthew Thau, et al.
Shock (Augusta, Ga.)|November 23, 2021
Relationships Between Age, Soluble Triggering Receptor Expressed on Myeloid Cells-1 (sTREM-1), and Mortality Among Critically Ill Adults: A Cohort StudyNeha A Sathe, Pavan K Bhatraju, Carmen Mikacenic, et al.
Critical Care Explorations|September 2, 2022
Presence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus-2 on Admission Is Associated With Decreased Mortality in COVID-19 Critical IllnessF Linzee Mabrey, Leila R Zelnick, Eric D Morrell, et al.
Critical Care Explorations|December 15, 2021
Plasma Soluble CD14 Subtype Levels Are Associated With Clinical Outcomes in Critically Ill Subjects With Coronavirus Disease 2019F Linzee Mabrey, Eric D Morrell, Pavan K Bhatraju, et al.
Journal of Critical Care|August 13, 2024
Normalization of IL-6 levels is associated with survival in critically ill patients with COVID-19Anahita Mostaghim, Neha A Sathe, F Linzee Mabrey, et al.
Critical Care Explorations|December 26, 2022
Plasma Interleukin-6 Predicts Clinical Decline After Completion of Dexamethasone Therapy in Severe COVID-19F Linzee Mabrey, Pavan K Bhatraju, Eric D Morrell, et al.
BMC Pulmonary Medicine|August 9, 2023
Evaluating construct validity of computable acute respiratory distress syndrome definitions in adults hospitalized with COVID-19: an electronic health records based approachNeha A Sathe, Su Xian, F Linzee Mabrey, et al.
CHEST Critical Care|June 4, 2025
Anti-CD14 treatment in patients with severe COVID-19: Clinical and biological effects in a Phase 2 randomized open-label adaptive platform clinical trialF Linzee Mabrey, Thomas R Martin, Carolyn S Calfee, et al.
Critical Care (London, England)|December 19, 2024
Urinary proteomics identifies distinct immunological profiles of sepsis associated AKI sub-phenotypesIan B Stanaway, Eric D Morrell, F Linzee Mabrey, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Innate Immunity|November 22, 2021
TLRs in COVID-19: How they drive immunopathology and the rationale for modulationF Linzee Mabrey, Eric D Morrell, Mark M Wurfel
AMIA ... Annual Symposium Proceedings. AMIA Symposium|March 21, 2022
Identifying ARDS using the Hierarchical Attention Network with Sentence Objectives FrameworkKevin Lybarger, Linzee Mabrey, Matthew Thau, et al.
Shock (Augusta, Ga.)|November 23, 2021
Relationships Between Age, Soluble Triggering Receptor Expressed on Myeloid Cells-1 (sTREM-1), and Mortality Among Critically Ill Adults: A Cohort StudyNeha A Sathe, Pavan K Bhatraju, Carmen Mikacenic, et al.
Critical Care Explorations|September 2, 2022
Presence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus-2 on Admission Is Associated With Decreased Mortality in COVID-19 Critical IllnessF Linzee Mabrey, Leila R Zelnick, Eric D Morrell, et al.
Critical Care Explorations|December 15, 2021
Plasma Soluble CD14 Subtype Levels Are Associated With Clinical Outcomes in Critically Ill Subjects With Coronavirus Disease 2019F Linzee Mabrey, Eric D Morrell, Pavan K Bhatraju, et al.
Journal of Critical Care|August 13, 2024
Normalization of IL-6 levels is associated with survival in critically ill patients with COVID-19Anahita Mostaghim, Neha A Sathe, F Linzee Mabrey, et al.
Critical Care Explorations|December 26, 2022
Plasma Interleukin-6 Predicts Clinical Decline After Completion of Dexamethasone Therapy in Severe COVID-19F Linzee Mabrey, Pavan K Bhatraju, Eric D Morrell, et al.
BMC Pulmonary Medicine|August 9, 2023
Evaluating construct validity of computable acute respiratory distress syndrome definitions in adults hospitalized with COVID-19: an electronic health records based approachNeha A Sathe, Su Xian, F Linzee Mabrey, et al.
CHEST Critical Care|June 4, 2025
Anti-CD14 treatment in patients with severe COVID-19: Clinical and biological effects in a Phase 2 randomized open-label adaptive platform clinical trialF Linzee Mabrey, Thomas R Martin, Carolyn S Calfee, et al.
Critical Care (London, England)|December 19, 2024
Urinary proteomics identifies distinct immunological profiles of sepsis associated AKI sub-phenotypesIan B Stanaway, Eric D Morrell, F Linzee Mabrey, et al.
Pageof 2